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Purpose: Exploration of the relationship between a novel paired box 6 (Pax6) mutant and Pax6 in Bufo raddei Strauch.
Methods: RT–PCR, yeast 2-hybrid system, and co-immunoprecipitation were used to analyze the Pax6 protein and its
mutant during embryonic eye development in Bufo raddei Strauch.
Results: We have cloned the Pax6 ORF sequence from Bufo raddei Strauch. Here we report the cloning of a novel
Pax6 homolog of Bufo raddei Strauch named Pax6 variant. Comparing the 2 genes, the homolog of ORF nucleotide
sequence is more than 99% in Bufo raddei Strauch; only the proline-serine-threonine(PST)-rich transaction domain differs.
The deduced amino acid sequences of PST region are 53.1% identical. An interaction was found between Pax6 and
Pax6  variant  via  yeast  2-hybrid  system;  with  further  study,  we  found  that  they  interacted  in  vivo  via  co-
immunopricipitation.
Conclusions: A Pax6 mutant was first found in Bufo raddei Strauch. Interaction between Pax6 and Pax6 variant may play
a critical role during eye development in Bufo raddei Strauch. This suggests that expression of Pax6 variant may play a
role and appears to be a necessity in eye development, but that Pax6 itself is still pivotal in eye development.
Paired  box  6  (Pax6)  is  expressed  throughout  eye
development [1-3], and has been reported to be a master of
eye development. However, in true moles (Talpidae), Pax6
was found to be dispensable [4], although it was recently
found to be pivotal in initiation of lens fiber cell differentiation
[5]. Pax6 is also important in the central nervous system. Via
alpha-crystallin,  Pax6  regulates  survival  of  dopaminergic
olfactory  bulb  neurons  [6].  In  the  forebrain,  accurate
expression  of  Pax6  is  important  for  cortical  progenitor
proliferation [7]; in the rat hindbrain, Pax6 is required for
coordinating  boundary-cell  specification,  and  within  the
hindbrain, boundary region neurogenesis can be reduced [8].
In the postnatal limbic system, Pax6 plays a key role in the
generation of multiple subtypes of neurons [9]. In postnatal
cerebellum development, Pax6 is pivotal in the life of the
developing granule cell [10], and by an essential cephalic
ectodermal patterning center, Pax6 can regulate craniofacial
form [11]. Pax6 is crucial for cell development; it plays an
essential role in controlling the expression of the key genes
involved in pancreatic alpha cell differentiation and function
[12]. In mouse embryonic stem cells, Pax6 can induce retinal
neuron progenitors [13], and the epidermal growth factor-
responsive neural stem cells can be regulated by Pax6 [14].
Overexpression  of  Pax6  can  change  development  and
function in some cells, and the level of Pax6 directly maintains
normal corneal epithelial cells [15], but inhibits the growth of
cultured  human  retinoblastoma  cells  [16].  Via  the  MET
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tyrosine  kinase  receptor,  Pax6  participates  in  cancer
progression [17]; some researchers have found that glioma
angiogenesis can be restrained by Pax6 [18]. Pax6 expression
levels  can  be  controlled  by  forkhead  box  G1  (Foxg1)  in
telencephalic progenitor proliferation cells [19]. Some genes,
like  sine  oculis  homeobox  3  (Six3)  and  orthodenticle
homeobox  (Otx),  may  play  a  prominent  role  in  Pax6
expression in the early development of the stalked crinoid
Metacrinus  rotundus  [20].  It  was  reported  that  Pax6  was
connected  with  hormones;  Pax6  can  restrain  androgen
receptors by reducing coactivators to AR target promoters
[21], and can influence islet function via its variant, which is
shown to reduce Pax6 expression in human islets [22]. In the
endocrine pancreas, some transcription factors are involved
in the activation of the glucagon gene, which is controlled by
Pax6 [23].
Pax6 includes 3 functional domains: the paired box, the
paired  homeobox,  and  the  proline,  serine,  threonine–rich
(PST-rich)  region  [24].  Some  Pax6  mutations  have  only
partial homeodomain or none at all [25,26]. The loss of 1
functional allele of Pax6 leads to mouse small eye [27,28],
Peter’s  anomaly,  and  congenital  cataracts  in  human  eye
development  [29,30].  Some  novel  mutations  in  Pax6  can
cause the classic aniridia phenotype [31]. In disease research,
some Pax6 mutant rats serve as a model for autism [32].
Pax6  homolog  has  now  been  described  in  other
invertebrates, such as flatworm, ribbon worm, C. elegans,
squid, sea urchin, and ascidian [33]. Some species also contain
a  second  DNA-binding  domain,  the  paired-type
homeodomain that is separated from the NH2-terminal [34,
35]. The COOH-terminal domain is not conserved between
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2698vertebrates,  Drosophila  eyeless,  and  the  ascidian  Pax6
protein, but they may have biochemical functions [36-39].
Most  mutations  of  Pax6  result  in  specific  defects  in  the
development of the eye; some can influence the nuclear signal
transfer, and others can influence the combination of the DNA
match domain [26]. Through direct or indirect protein–protein
interaction,  the  efficiency  of  transcription  factor  can  be
improved [40]. Pax6 mutations lead to several ocular defects;
with Pax6-consensus binding sequence, Pax6(5a)-consensus
binding  sequence,  and  homeodomain  binding  sequence
containing luciferase reporters, the transactivation potential
of Pax6(5a)-G36A was enhanced [41].
We conducted a study in amphibians, focusing on Bufo
raddei strauch, which is distributed in the northern part of
China, and is even found in saline-alkali soil, given its strong
adaptability. It serves as the consumer lying at the base of the
food  chain;  it  is  an  important  species  in  maintaining  the
diversity of species and the stability of the ecosystem. This
species is gonochorism and ovulate in water and then the eggs
grow into tadpoles. In winter, when the temperature falls
below 10 °C, they initiate hibernation in caves. Bufo raddei
strauch belongs to anura bufonidae. The optic vesicle can be
clearly observed when the embryon of Bufo raddei strauch
reach 6 days; after 7.5 days, the pigment of cornea begins to
reduce and the lens begins to appear.
METHODS
Animal: Bufo raddei Strauch embryos were obtained at 6
days’ growth.
Gene clones and protein expression: Total RNA was isolated
from the Bufo raddei Strauch when the embryos grew to 6
days,  and  then  was  reverse  transcribed  into  cDNA.  The
sequences of the entire open reading frame for the full-length
Bufo raddei Strauch Pax6 and Pax6 variant was amplified by
means of polymerase chain reaction; at the same time, vectors
were successfully constructed (Table 1).
The  plasmid  for  pET-28-Gfp-Pax6  included  a  partial
sequence of Pax6 ORF, only 231 bp in the PST region, which
has 432 bp. The pET-28-Gfp-Pax6-variant has only 147 bp in
PST region, which has 348 bp of Pax6 variant ORF sequence.
All recombinants were verified by DNA sequencing. Four
proteins were expressed in Rosetta (DE3) cells and purified
via  nickel  affinity  column;  these  were  Pax6-His,  Pax6-
variant-His  protein,  Gfp-Pax6-His,  and  Gfp-Pax6-variant-
His.
Preparation of antiserum against Gfp-Pax6 and Gfp-Pax6
variant: Per Bradford, the concentration of purified fusion
proteins was examined. First, 1 mg of Gfp-Pax6 protein was
mixed with 1 ml Freund's incomplete adjuvant (Invitrogen,
Shanghai, China), and then injected into a rabbit. After 3 days,
1 ml Freund's incomplete adjuvant (Invitrogen) was replaced
by 1 ml Freund's complete adjuvant, which was mixed with
antigen protein, and was injected into the rabbit. The same
operation was conducted 3 times at weekly intervals. At the
same time, Gfp-Pax6-variant protein replaced the Gfp-Pax6
protein, and was injected into another rabbit using the same
method.  Finally,  polyclonal  antisera  were  obtained  and
purified.
Yeast two-hybrid system: Four recombinants were obtained
by primers, as shown in Table 2. The entire open reading
frame of Pax6 and Pax6 variant was cloned and digested by
Nde1  and  EcoR1  (Takara,  Tokyo,  Japan).  They  were
respectively linked to pGBK-T7 vectors which were digested
by the same enzymes. Meanwhile, Pax6 and Pax6 variant
were digested by EcoR1 and Xho1, respectively, and linked
to  pGAD-T7  vectors,  which  were  digested  by  the  same
enzymes.  These  4  recombinants  were  verified  by  DNA
sequencing,  and  were  transferred  into  Yeast  Y190.  Six
experimental groups were constructed: Pax6-pGAD-T7 and
Pax6-variant-pGBK-T7, Pax6-pGBK-T7 and Pax6-variant-
pGAD-T7,  Pax6-pGAD-T7  and  pGBK-T7,  Pax6-variant-
pGBK-T7 and pGAD-T7, Pax6-pGBK-T7 and pGAD-T7,
and Pax6-variant-pGAD-T7 and pGBK-T7. Each group was
transferred  into  Yeast  Y190,  so  that  6  different  yeast
expression systems were produced. After they grew in culture
TABLE 1. PRIMERS OF PLASMID WHICH WAS CONSTRUCTED FOR PROTEIN PURIFICATION.
Plasmid Primers Vector Enzyme cut
sites
Fragment
size
pET-28-Pax-6 5′-CCGGAATTCATGCAGAACAGTCACAGCGGA-3 pET28 EcoR I, Hind III 1270
  5′-CCCAAGCTTCTGTAGTCTTGGCCAGTACTG-3′      
pET-28-Pax-6 variant 5′-CCGGAATTCATGCAGAACAGTCACAGCGGA-3 pET28 EcoR I, Hind III 1182
  5′-AAAAAGCTTTAAAATACTGCTGAACATCC-3′      
pET-28-Gfp-Pax-6 5′-AAACCATGGGTAAAGGAGAAGAAC-3 pET28 NcoI, Hind III 948
  5′GTCTGGCTGGGTACAGGGGGTTTGTATAGTTCATCCATG-3′      
  5′CATGGATGAACTATACAAACCCCCTGTACCCAGCCAGAC-3′      
  5′TTTAAGCTTCTGTAGTCTTGGCCAGTACTG-3′      
pET-28-Gfp-Pax-6-variant 5′-AAACCATGGGTAAAGGAGAAGAAC-3′ pET28 NcoI, Hind III 864
  5′-CTCCAGGGGAAATGAGACTTTGTATAGTTCATCCATG-3′      
  5′-CATGGATGAACTATACAAAGTCTCATTTCCCCTGGAG-3′      
  5′-AAAAAGCTTTAAAATACTGCTGAACATCC-3      
               The Table displays the specific primers of each gene, and appropriate vector, enzyme cut sites and product length.
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2699medium, which lacked Leu and Trp, for 3 days, the surviving
yeast colony was transferred to a culture medium containing
dicyandiamide and that lacked Leu, Trp, and His, where some
of the yeast colony still continued to grow. The surviving yeast
colony was transferred into nitrocellulose membrane, frozen
by liquid nitrogen for 30 s, then melted at room temperature.
Then  the  membrane  carrying  some  yeast  colony  was
incubated in buffer (60 mM Na2HPO4, 40 mM NaH2PO4,
1 mM KCl, 5 mM MgSO4, 0.27% (v/v) β-mercaptoethanol,
35mg/ml X-gal) to observe color change.
Co-immunoprecipitation  (Co-IP):  The  embryos  were
collected at 6 days after fertilization. The samples were pooled
and ground to a powder with liquid nitrogen. The powder was
dissolved in lysis buffer that contained 100 mM Na2HPO4,
1  mM  EDTA,  1  mM  EGTA,  5%  (v/v)  glycerol,  5  mM
MgCl2, 100 mM KCl, 10 mM NaCl, 0.1% (v/v) Triton X-100
(Invitrogen),  0.1%  (V/V)  Tween-20  (Invitrogen),  10  mM
Tris-HCl, 35μg/ml PMSF (Invitrogen), 0.5μg/ml Leupeptin
(Invitrogen) pH 7.5) [42,43]. After incubation on ice for 30
min, it was centrifuged at 13,000× g at 4 °C for 30 min. The
supernatant  was  collected  and  we  proceeded  with
determination  of  protein  concentration.  Then,  1  mg  total
protein was incubated with 1 μg rabbit anti-gfp-Pax6 antibody
in a total volume of 1 ml. We use anti-GST antibody in a
negative control group. After 2 h incubation at 4 °C, the
protein  and  antibody  mix  was  incubated  with  20  μl  of
magnetic  Protein  A  (Sigma-Aldrich,  Shanghai,  China)
particles at 4 °C for 1 night with shaking. Particles were
separated with a magnetic stand and then washed 4 times with
wash buffer: TBST. Particles were boiled in 5× loding buffer:
0.25 mol/l Tris-HCl, pH 6.8, 10% SDS, 0.5% bromophenol
blue, 5% β-mercaptoethanol, 50% (v/v) glycerol. Western
blotting experiments were performed in biologic replicates.
Taking the same method, we use rabbit anti-gfp-Pax6-variant
antibody  to  replace  rabbit  anti-gfp-Pax6  antibody.
Experiments were also performed in biologic replicates.
RESULTS
The  Pax6  gene  of  Bufo  raddei  Strauch  has  3  functional
domains. The homology of ORF region is 83% in Xenopus
laevis. In humans and mice, the homology is 84% and 82%,
respectively. The homology of Pax6 protein is greater than
95% in vertebrates. The homology of the paired box is 98%,
the paired homeobox is 100%, and PST region is 96% in
Xenopus laevis.
The ORF region of Pax6 variant has 1,182 bp. The locus
of Pax6 variant is FJ175151 in Genebank. Compared with
Pax6,  the  homolog  of  ORF  nucleotide  sequence  of  Bufo
raddei Strauch is more than 99% and compared with the
Pax6 variant B of Xenopus laevis, the homolog is 84%. The
analysis based on DNAMAN software (Lynnon Corporation,
Quebec,  Canada)  indicates  the  Pax6  variant  also  has  3
functional domains: the paired box, the paired homeobox, and
the PST region. The Pax6 variant protein has 393 amino acids,
among which only the PST region differs from Pax6 of Bufo
raddei Strauch. Compared with the PST region of Pax6, Pax6
variant protein loses 50 amino acids in 345–394 AA, and
because of frame shift, the 395–422 AA differ from the same
region of the Pax6 protein, and in the end of the PST region,
the Pax6 variant adds 21 amino acids (Figure 1).
Pax6  and  Pax6  variant  of  Bufo  raddei  Strauch  were
cloned and recombinant proteins were expressed successfully
in Rosetta (DE3). By SDS–PAGE, 46 kDa and 43 kDa protein
bands were observed (Figure 2). His-tagged fusion proteins
were purified by a nickel affinity column. At the same time,
Gfp-Pax6  and  Gfp-Pax6-variant  protein  were  expressed
(Figure 2) and purified, and they were used as antigens and
injected into the rabbit.
Yeast two-hybrid system: Six different Yeast expression
systems  were  produced  successfully.  When  they  grew  in
culture medium lacking Leu, Trp and His for 3 days, only 2
groups  could  grow,  they  are  Pax6-pGAD-T7  and  Pax6-
variant-pGBK-T7,  and  Pax6-pGBK-T7  and  Pax6-variant-
pGAD-T7. Each group was transferred to nitrocellulose filter
membrane, after incubation in x-gal buffer for 8 h at 30 °C,
the color of the yeast colony turned blue (Figure 3). This
experiment  shows  only  Pax6  and  Pax6  variant  proteins
express in the same cell of yeast y190, the cell activates the
reporter gene, and histidine gene 3 (HIS3) and β-galactosidase
(LacZ) were expressed, so the yeast colony could grow in a
TABLE 2. PRIMERS OF PLASMID WHICH WAS CONSTRUCTED FOR YEAST TWO-HYBRID SYSTEM.
Plasmid Primers Vectors Enzyme cut
sites
Fragment
size
Pax-6- pGBK-T7 5′-GGAATTCCATATGATGCAGAACAGTCACAGCGG-3′ pGBK-T7 Nde1, EcoR1 1288
  5′-CCGGAATTCCTGTAGTCTTGGCCAGTACTG-3′      
Pax-6-pGAD-T7 5′-CCGGAATTCATGCAGAACAGTCACAGCGG-3′ pGAD-T7 EcoR1, Xho1 1285
  5′-CCGCTCGAGCCTGTAGTCTTGGCCAGTACTG-3′      
Pax-6-variant-pGAD-T7 5′-CCGGAATTCATGCAGAACAGTCACAGCGG-3′ pGAD-T7 EcoR1, Xho1 1198
  5′-CCGCTCGAGCTAAAATACTGCTGAACATCC-3′      
Pax-6-variant- pGBK-T7 5′-GGAATTCCATATGATGCAGAACAGTCACAGCGG-3′ pGBK-T7 Nde1, EcoR1 1201
  5′-CCGGAATTCTAAAATACTGCTGAACATCC-3′      
               The Table displays the specific primers of each gene, and appropriate vector, enzyme cut sites and product length.
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2700culture medium that lacked His, and the color of the colony
turned blue when incubated in x-gal buffer. The results show
that Pax6 and Pax6-variant interact in yeast y190.
Co-immunoprecipitation: First, the rabbit anti-Gfp-Pax6
antibody was used to do immunoprecipitation, rabbit anti-
GST antibody was used in negative control, then rabbit anti-
Gfp-Pax6  antibody  was  used  to  do  western  blotting.  The
results show that a heavy chain of antibodies was found in the
negative group and experimental group (Co-IP), and Pax6
protein was found in the experimental group and 2 positive
controls.  When  using  Gfp-Pax6-variant  antibody  to  do
western  blotting,  the  Pax6-His  was  replaced  with  Pax6
variant-His in the inputs. The results show that Pax6-variant
protein was found in the experiment and 2 positive controls.
When  using  rabbit  anti-Gfp-Pax6-variant  antibody  to  do
immunoprecipitation,  first  using  anti-Gfp-Pax6-variant
Figure  1.  Structural  analysis  of  Pax6
ORF  and  Pax6  variant  ORF  of  Bufo
raddei  Strauch.  There  is  only  53.1%
similarity in PST between the Pax6 and
Pax6  variant  in  homology  analysis
employing  DNAMAN  software
(Lynnon  Corporation,  Quebec,
Canada). From the 67th amino acid to
the 3 'end, Pax6 variant protein has 49
Amino acids while Pax6 has 78 amino
acids.
Figure  2.  SDS–PAGE  for  induced
expression of recombinant proteins. The
4  recombinant  proteins  are  Pax6-
variant-His,  Pax6-His,  Gfp-Pax6-His,
and Gfp-Pax6-variant-His, which were
expressed  in  E.  coli  Rosetta  (DE3).
Their respective molecular weighs are
43 kDa, 46 kDa, 35 kDa, 32 kDa. All of
sample 1 consists of induced proteins;
all  of  sample  2  is  negative  controls,
which were not induced.
Molecular Vision 2011; 17:2698-2705 <http://www.molvis.org/molvis/v17/a292> © 2011 Molecular Vision
2701antibody to do western blotting, Pax6-variant was found in
both the experiment and 2 positive controls. Then using anti-
Gfp-Pax6 antibody to do western blotting, Pax6 variant-His
was replaced by Pax6-His of the inputs; Pax6 protein was
found in both the experiment and 2 positive controls (Figure
4). The experimental group shows that Pax6 and Pax6 variant
can form a complex, through rabbit anti-Gfp-Pax6 antibody
or  rabbit  anti-Gfp-Pax6-variant  antibody,  combined  with
magnetic Protein A particles. These results suggest that Pax6
and Pax6-variant of Bufo raddei Strauch interact in vivo.
DISCUSSION
The adult Bufo raddei Strauch lives mostly on land and feeds
on small invertebrates such as insects. Their feeding habits
change after they undergo complete metamorphosis, which
indicates a kind of adaption to natural selection during its long
evolution; thus, they may be higher than Xenopus in their
evolutionary position. We first found a new Pax6 mutant of
normal Bufo raddei Strauch. The Pax6 mutant may be caused
by evolution. Several researchers found that most mutants of
Pax6 were lost in 3′ sequences [44]. The mutant proteins
combine with downstream genes that differ from Pax6 [45,
46].  The  PST  region  of  mutants  may  contain  a  part  of
transcription activation [40]. Some mutations have been found
to occur in the COOH-terminal of Pax6, which contains the
DNA-binding domains but has lost most of the transactivation
domain. These mutants are dominant-negative in transient
transfection assays when they are co-expressed with wild-type
Pax6  [47].  A  mutant  of  Pax6  was  found  in  normal  Bufo
raddei Strauch; it is located in the PST region of Pax6. It is
interesting  that  it  can  exist  stably  in  normal  Bufo  raddei
Strauch,  which  differs  from  previous  reports  that  some
mutants can lead to developmental problems in the eyes.
This study found that Pax6 and Pax6 variant were able to
interact in yeast, and the co-immunoprecipitation experiment
tells us that they still have a mutual effect in Bufo raddei
Strauch.  The  results  indicate  that  Pax6  variant  and  Pax6
protein can form a compound, and can have influence on the
function of Pax6. Because the gst-Pax6-variant and gst-Pax6
proteins  were  not  expressed  and  purified,  whether  the
interactions were direct or indirect is not known from the pull-
down experiment, so it is possible that some other proteins are
involved in the interactions. What is most significant is that
the mutant protein can regulate Pax6.
Figure  3.  Yeast  2-hybrid  system.  A:
Yeast  Y190  grow  in  culture  medium
without Leu and Trp for 3 days at 30
degrees centigrade; Pax6-pGBK-T7 and
Pax6-variant-pGAD-T7    were        trans-
formed   into   the     first     yeast      colony,
Pax6-pGAD-T7  and  Pax6-variant-
pGBK-T7  were  transformed  into  the
second yeast colony. B: Yeast colony of
the experimental group grew in culture
medium  containing  dicyandiamide,
without Leu, Trp, and His, after growing
for 3 days at 30 °C. C: yeast colony
transformed  into  nitrocellulose  filter
membrane; adding buffer containing x-
gal, the color is displayed blue.
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2702Pax6 is a key regulator in eye development; it expresses
early in cells fated to form the eye and parts of the forebrain,
hindbrain, and spinal cord [48]. As an early marker of corneal
epithelial cell differentiation, Pax6 has high-level expression
in early cell cultures, but then is found at very low levels in
proliferating  cells  [49].  Thus,  we  infer  that  Pax6  is  also
reduced  in  Bufo  raddei  Strauch  eye  development.  The
combination of Pax6 and pax6 variant protein may result in
the downregulation of Pax6 by their interaction.
Some  elements  of  transcriptional  activation  involve
leucine, proline, glutamic acid, serine, and threonine [50]. We
found in the PST region of Pax6 that the ratio of proline,
serine, and threonine were 15%, 19%, and 12%, respectively,
but in the Pax6 variant, the ratios were 10%, 17%, and 11%,
respectively. Using 3D-PSSM software, we found that Pax6
had 2 more α-helixes than the Pax6 variant protein in the PST
region, which makes it possible that the Pax6 and Pax6 variant
have mutual effects and form a complex structure.
Mutations in Pax6 lead to a variety of ocular anomalies
in human beings and mice. However in Bufo raddei Strauch,
the Pax6 variant has no impact on pathological changes, but
may  have  a  role  in  eye  development.  The  mutual  effect
between Pax6 and Pax6 variant may be important for eye
development; we assume it to be a special evolution in Bufo
raddei Strauch. Pax6 is still pivotal for eye development, but
the expression of Pax6 variant appears to be a necessity.
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